Project Grant R03HD110955
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $352,674 to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany to conduct research on the molecular mechanisms underlying terminal nerve development, GnRH-1 neuronal migration, and olfactory bulb formation in normal and pathological...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $746,999 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Broad Institute, Inc. to characterize the genetic etiology of delayed puberty and rare congenital forms of infertility. The research project aims to: 1) Define the spectrum of genomic variants contributing to idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome...
- This Project Grant award of $170,640 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to investigate the role of the FGFR1 signaling pathway in the intersection between reproduction and metabolism. The primary objectives of this 5-year research project are to: (1) conduct a recall-by-genotype study and in-depth neuroendocrine and metabolic phenotyping in...
- This $539,999 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate the role of the NKX2.1 homeobox transcription factor in nervous system development. The research, to be conducted by Kennesaw State University, will utilize the nematode Caenorhabditis elegans as a model organism to better understand how NKX2.1 and related...
- This Project Grant award of $241,380 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) aims to advance the understanding of neurodevelopmental disorders (NDDs) and develop innovative therapies. The research program, led by researchers at Boston Children's Hospital, will use single-cell epigenomic technologies to link pathogenic variants in chromatin regulators, such as...
- The federal Project Grant award of $139,086 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to better understand the metabolic mechanisms underlying phenotypes associated with kynurenine 3-monooxygenase (KMO) deficiency, a novel congenital nicotinamide adenine dinucleotide (NAD) deficiency disorder. The award, with a period of performance...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will lay the foundation for developing a molecular therapy for ADNP syndrome. The $395,009 award to the University of California, Davis will fund research to: 1) test the mechanism of action of antisense oligonucleotides (ASOs) that can increase ADNP protein expression in human neurons, and 2)...
- This Project Grant award of $425,628.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research federal grant program (CFDA 93.865), aims to elucidate the role of the FMR1 gene in regulating reproductive function. The overarching goal is to investigate the molecular mechanisms by which FMR1 gene mutations, which cause Fragile X syndrome and premature ovarian failure, impact ovarian function...
- This $769,995 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research at Northwestern University to investigate the functional genetic basis of KCNB1 encephalopathy. This rare and severe neurodevelopmental disorder is characterized by developmental delay, intellectual disability, seizures, and elevated mortality risk. The research aims to...
- This Project Grant award, totaling $419,204.00 and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to characterize genetic variants associated with Noonan Syndrome with Loose Anagen Hair (NSLH), a rare developmental disorder affecting craniofacial features, the heart, digestive system, and neural development. The University of Kentucky...
FUNCTIONAL DISSECTION OF A NOVEL CAUSATIVE GENE FOR KALLMANN SYNDROME - PROJECT SUMMARY/ABSTRACT KALLMANN SYNDROME (KS) IS A CONDITION CHARACTERIZED BY DELAYED OR ABSENT PUBERTY AND AN IMPAIRED SENSE OF SMELL. KS RESULTS FROM THE DEFICIENCY OF EARLY DEVELOPMENT AND MIGRATION OF GNRH-SYNTHESIZING NEURONS AND OLFACTORY NERVES. BESIDES ANOSMIA, THERE ARE SEVERAL OTHER ASSOCIATED NON-REPRODUCTIVE FEATURES, INCLUDING MIDLINE FACIAL, DENTAL, AND DIGIT ANOMALIES, HEARING IMPAIRMENT, BIMANUAL SYNKINESIS, AND RENAL ABNORMALITIES. KS IS CLINICALLY AND GENETICALLY HETEROGENEOUS AND NOT STRICTLY A MONOGENIC MENDELIAN DISEASE. THERE ARE >25 DIFFERENT CAUSAL GENES, EACH ACCOUNTING FOR LESS THAN 10% OF KS CASES, THAT HAVE BEEN IDENTIFIED TO DATE, YET THE GENETIC BASIS OF THE VAST MAJORITY OF KS CASES REMAINS UNKNOWN. THE KS-ASSOCIATED GENES EITHER ACT ALONE (MONOGENIC) OR IN COMBINATION (OLIGOGENIC). HOWEVER, THE MOLECULAR MECHANISMS THAT MODULATE THE OLIGOGENIC INTERACTIONS ARE FAR FROM BEING ELUCIDATED SINCE THE EXACT ROLES OF SOME SUSCEPTIBILITY GENES IN THE REGULATION OF THE GNRH/ OLFACTORY NERVOUS SYSTEM ARE YET TO BE DISCOVERED. THEREFORE, MOLECULAR CHARACTERIZATION OF NEWLY IDENTIFIED KS CAUSATIVE GENES AND THEIR ASSOCIATED SIGNALING PATHWAYS IS CRUCIAL FOR FULLY DETERMINING THE GENETIC CAUSE OF KS. THE CURRENT PROPOSAL AIMS TO UNDERSTAND HOW NEURON-DERIVED NEUROTROPHIC FACTOR (NDNF), A NOVEL CAUSATIVE GENE FOR KS, MODULATES BMP SIGNALING. IF SUCCESSFUL, THE RESULTS WILL PROVIDE MECHANISTIC INSIGHT UNDERLYING KS, INFORM GENETIC COUNSELING OF KS, AND, IN THE LONG RUN, CONTRIBUTE TO A TIMELY DIAGNOSIS AND TREATMENT TO MINIMIZE PHYSICAL AND PSYCHOLOGICAL EFFECTS ON KS PATIENTS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/17/25 | ||
| Not listed | $161.5k | 9/12/23 |